Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
SIOS, 15% Decrease in Ordinary Profit for The Current Fiscal Year
3744 SIOS Corporation 【J-GAAP】
Earnings ReportSIOS Corporation <3744> [TSE Std] announced its financial results after the market closed on February 14th (16:30). The consolidated ordinary profit/loss for the fiscal year ending December 2024 turned into a profit of 189 million yen (compared to a loss of 15 million yen in the previous period). In the fiscal year ending December 2025, the consolidated ordinary profit is expected to decrease by 15.3% from the previous period to 160 million yen.
In the most recent three-month period, from October to December (4Q), the consolidated ordinary profit grew 19.4% from the same period last year, reaching 148 million yen. The operating profit/loss margin improved from -0.3% in the same period last year to 2.5%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2022 | 14,420 | -572 | -499 | -639 | -73.8 | 10 | Feb 2, 2023 | J-GAAP |
Dec, 2023 | 15,889 | -208 | -15 | -18 | -2.2 | 5 | Feb 8, 2024 | J-GAAP |
Dec, 2024 | 20,561 | 35 | 189 | 351 | 40.6 | 0 | Feb 14, 2025 | J-GAAP |
YoY | +29.4% | - | - | - | - |
Full Year Results vs. Previous Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2024 Guidance | 20,561 | 35 | 183 | 351 | 40.4 | 0 | Feb 12, 2025 | J-GAAP |
Dec, 2024 Results | 20,561 | 35 | 189 | 351 | 40.6 | 0 | Feb 14, 2025 | J-GAAP |
Revision Rate | 0.0% | 0.0% | +3.3% | 0.0% | +0.3% |
Current Period Guidance
H1 Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jan - Jun, 2024 | 11,804 | -18 | 57 | 23 | 2.7 | 0 | Aug 8, 2024 | J-GAAP |
Jan - Jun, 2025 Guidance | ー | ー | ー | ー | - | 0 | Feb 14, 2025 | J-GAAP |
YoY | - | - | - | - | - |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2023 | 15,889 | -208 | -15 | -18 | -2.2 | 5 | Feb 8, 2024 | J-GAAP |
Dec, 2024 | 20,561 | 35 | 189 | 351 | 40.6 | 0 | Feb 14, 2025 | J-GAAP |
Dec, 2025 Guidance | 19,000 | 70 | 160 | 100 | 11.5 | 0 | Feb 14, 2025 | J-GAAP |
YoY | -7.6% | +100.0% | -15.3% | -71.5% | -71.6% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Dec, 2023 | 4,188 | -14 | 124 | 168 | 20.4 | -0.3 | Feb 8, 2024 | J-GAAP |
Jan - Mar, 2024 | 6,405 | 18 | 57 | 38 | 4.5 | 0.3 | May 8, 2024 | J-GAAP |
Apr - Jun, 2024 | 5,399 | -36 | 0 | -15 | -1.8 | -0.7 | Aug 8, 2024 | J-GAAP |
Jul - Sep, 2024 | 3,913 | -68 | -16 | -35 | -4.3 | -1.7 | Nov 7, 2024 | J-GAAP |
Oct - Dec, 2024 | 4,844 | 121 | 148 | 363 | 42.0 | 2.5 | Feb 14, 2025 | J-GAAP |
YoY | +15.7% | - | +19.4% | +116.1% | +106.2% |
Related Articles
ARCHITECTS STUDIO JAPAN, Oct-Dec (3Q) Net Income Loss Widens
MRT, Returning to Profitability This Year
KENKO Mayonnaise, Oct-Dec (3Q) Ordinary Profit Decreases by 10%
EM SYSTEMS, 39% Decrease in Ordinary Profit for The Current Fiscal Year, Increased Previous Year's Dividend by 6 yen, Plan to Continue the 35 yen Policy This Fiscal Year as Well
EduLab, Oct-Dec (1Q) Ordinary Profit Turns to Profit, Exceeds Full-Year Plan
SPANCRETE, Oct-Dec (3Q) Ordinary Profit Loss Widens
RS Technologies, 6% Increase in Ordinary Profit, Update Record High for Second Consecutive Term, Dividend Raised by 5 yen
Cyfuse Biomedical, The Current Fiscal Year's Net Income to Widen
SUS, Oct-Dec (1Q) Ordinary Profit Increases by 71%
COPRO-HOLDINGS, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 46%, Oct-Dec Ordinary Profit Increases by 35%